These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23544173)

  • 21. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.
    Roberts WG; Ung E; Whalen P; Cooper B; Hulford C; Autry C; Richter D; Emerson E; Lin J; Kath J; Coleman K; Yao L; Martinez-Alsina L; Lorenzen M; Berliner M; Luzzio M; Patel N; Schmitt E; LaGreca S; Jani J; Wessel M; Marr E; Griffor M; Vajdos F
    Cancer Res; 2008 Mar; 68(6):1935-44. PubMed ID: 18339875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal adhesion kinase: from biological functions to therapeutic strategies.
    Tan X; Yan Y; Song B; Zhu S; Mei Q; Wu K
    Exp Hematol Oncol; 2023 Sep; 12(1):83. PubMed ID: 37749625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel small molecule inhibitor of FAK and IGF-1R protein interactions decreases growth of human esophageal carcinoma.
    Ucar DA; Cox A; He DH; Ostrov DA; Kurenova E; Hochwald SN
    Anticancer Agents Med Chem; 2011 Sep; 11(7):629-37. PubMed ID: 21707510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
    Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
    Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.
    Shanthi E; Krishna MH; Arunesh GM; Venkateswara Reddy K; Sooriya Kumar J; Viswanadhan VN
    Expert Opin Ther Pat; 2014 Oct; 24(10):1077-100. PubMed ID: 25113248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids.
    von Sengbusch A; Gassmann P; Fisch KM; Enns A; Nicolson GL; Haier J
    Am J Pathol; 2005 Feb; 166(2):585-96. PubMed ID: 15681841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and evaluation of FAK inhibitors with a 5-fluoro-7H-pyrrolo[2,3-d]pyrimidine scaffold as anti-hepatocellular carcinoma agents.
    Tan H; Liu Y; Gong C; Zhang J; Huang J; Zhang Q
    Eur J Med Chem; 2021 Nov; 223():113670. PubMed ID: 34214842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide.
    Golubovskaya VM; Huang G; Ho B; Yemma M; Morrison CD; Lee J; Eliceiri BP; Cance WG
    Mol Cancer Ther; 2013 Feb; 12(2):162-72. PubMed ID: 23243059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors.
    François RA; Maeng K; Nawab A; Kaye FJ; Hochwald SN; Zajac-Kaye M
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal adhesion kinase autophosphorylation inhibition decreases colon cancer cell growth and enhances the efficacy of chemotherapy.
    Heffler M; Golubovskaya VM; Dunn KM; Cance W
    Cancer Biol Ther; 2013 Aug; 14(8):761-72. PubMed ID: 23792569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FERM control of FAK function: implications for cancer therapy.
    Lim ST; Mikolon D; Stupack DG; Schlaepfer DD
    Cell Cycle; 2008 Aug; 7(15):2306-14. PubMed ID: 18677107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal adhesion kinase promotes the aggressive melanoma phenotype.
    Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
    Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
    Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
    Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells.
    Liu W; Bloom DA; Cance WG; Kurenova EV; Golubovskaya VM; Hochwald SN
    Carcinogenesis; 2008 Jun; 29(6):1096-107. PubMed ID: 18263593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting FAK scaffold functions inhibits human renal cell carcinoma growth.
    Béraud C; Dormoy V; Danilin S; Lindner V; Béthry A; Hochane M; Coquard C; Barthelmebs M; Jacqmin D; Lang H; Massfelder T
    Int J Cancer; 2015 Oct; 137(7):1549-59. PubMed ID: 25809490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated extracellular calcium ions accelerate the proliferation and migration of HepG2 cells and decrease cisplatin sensitivity.
    Xu H; Zhou Y; Guo J; Ling T; Xu Y; Zhao T; Shi C; Su Z; You Q
    J Biomed Res; 2023 Sep; 37(5):340-354. PubMed ID: 37750331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis.
    Luo M; Guan JL
    Cancer Lett; 2010 Mar; 289(2):127-39. PubMed ID: 19643531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence.
    Sun CK; Ng KT; Sun BS; Ho JW; Lee TK; Ng I; Poon RT; Lo CM; Liu CL; Man K; Fan ST
    Br J Cancer; 2007 Jul; 97(1):50-7. PubMed ID: 17551499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.
    Aboubakar Nana F; Lecocq M; Ladjemi MZ; Detry B; Dupasquier S; Feron O; Massion PP; Sibille Y; Pilette C; Ocak S
    Mol Cancer Ther; 2019 Jan; 18(1):17-27. PubMed ID: 30352800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of focal adhesion kinase by tumor direct injection of small interfering RNA decreases in vivo tumor growth.
    Tsutsumi K; Yamaura T; Nakajima M; Honda T; Kasaoka T
    Cancer Biol Ther; 2009 Jul; 8(13):1292-9. PubMed ID: 19458494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.